المؤلفون: Reinholm, Arttu, Maljanen, Sari, Jalkanen, Pinja, Altan, Eda, Tauriainen, Sisko, Belik, Milja, Skön, Marika, Haveri, Anu, Österlund, Pamela, Iakubovskaia, Alina, Pasternack, Arja, Naves, Rauno A., Ritvos, Olli, Miettinen, Simo, Häkkinen, Hanni K., Ivaska, Lauri, Tähtinen, Paula A., Lempainen, Johanna, Kantele, Anu, Kakkola, Laura, Julkunen, Ilkka, Kolehmainen, Pekka

المساهمون: Department of Physiology, Medicum, Growth factor physiology, Veterinary Biosciences, HUS Helsinki and Uusimaa Hospital District, Infektiosairauksien yksikkö, Department of Virology, Department of Medicine, HUS Inflammation Center

مصطلحات موضوعية: 3121 General medicine, internal medicine and other clinical medicine

وصف الملف: application/pdf

العلاقة: Reinholm , A , Maljanen , S , Jalkanen , P , Altan , E , Tauriainen , S , Belik , M , Skön , M , Haveri , A , Österlund , P , Iakubovskaia , A , Pasternack , A , Naves , R A , Ritvos , O , Miettinen , S , Häkkinen , H K , Ivaska , L , Tähtinen , P A , Lempainen , J , Kantele , A , Kakkola , L , Julkunen , I & Kolehmainen , P 2024 , ' Neutralizing antibodies after the third COVID-19 vaccination in healthcare workers with or without breakthrough infection ' , Communications Medicine , vol. 4 , no. 1 , 28 . https://doi.org/10.1038/s43856-024-00457-3Test; RIS: urn:9D570A9FEFF8E270B1F6A82F60063BFA; RIS: Reinholm2024; ORCID: /0009-0002-1107-522X/work/159028027; ORCID: /0000-0002-6088-4245/work/159029800; http://hdl.handle.net/10138/575007Test; 792d0022-a479-45e1-8364-07b391ebde9d; 001172587100002

الإتاحة: http://hdl.handle.net/10138/575007Test

المؤلفون: Belik, Milja, Liedes, Oona, Vara, Saimi, Haveri, Anu, Pöysti, Sakari, Kolehmainen, Pekka, Maljanen, Sari, Huttunen, Moona, Reinholm, Arttu, Lundberg, Rickard, Skön, Marika, Österlund, Pamela, Melin, Merit, Hänninen, Arno, Hurme, Antti, Ivaska, Lauri, Tähtinen, Paula A., Lempainen, Johanna, Kakkola, Laura, Jalkanen, Pinja, Julkunen, Ilkka

المساهمون: Academy of Finland, Jane ja Aatos Erkon Säätiö, Sigrid Juséliuksen Säätiö, Turun Yliopistosäätiö

المصدر: Frontiers in Immunology ; volume 14 ; ISSN 1664-3224

مصطلحات موضوعية: Immunology, Immunology and Allergy

الإتاحة: https://doi.org/10.3389/fimmu.2023.1099246Test

المؤلفون: Belik, Milja, Jalkanen, Pinja, Lundberg, Rickard, Reinholm, Arttu, Laine, Larissa, Väisänen, Elina, Skön, Marika, Tahtinen, Paula A., Ivaska, Lauri, Pakkanen, Sari H., Häkkinen, Hanni K., Ortamo, Eeva, Pasternack, Arja, Ritvos, Mikael A., Naves, Rauno A., Miettinen, Simo, Sironen, Tarja, Vapalahti, Olli, Ritvos, Olli, Österlund, Pamela, Kantele, Anu, Lempainen, Johanna, Kakkola, Laura, Kolehmainen, Pekka, Julkunen, Ilkka

المساهمون: University of Helsinki, Infektiosairauksien yksikkö, Helsinki University Hospital Area, Medicum, Department of Physiology, Faculty of Medicine, Department of Virology, HUSLAB, Helsinki One Health (HOH), Viral Zoonosis Research Unit, Emerging Infections Research Group, Veterinary Biosciences, Veterinary Microbiology and Epidemiology, Growth factor physiology, Department of Medicine

مصطلحات موضوعية: IMMUNOGENICITY, MULTICENTER, BNT162B2, 3121 General medicine, internal medicine and other clinical medicine

وصف الملف: application/pdf

العلاقة: We thank Soili Jussila, Anne Suominen, Anne-Mari Pieniniemi, and Outi Debnam for technical assistance. This study was supported by the Academy of Finland (grant number 337530 to I.J., 336439 and 335527 to A.K., and 339512 to L.K.), Jane and Aatos Erkko Foundation (grant numbers 3067-84b53 and 5360-cc2fc to I.J., and 5359-89ef7 to O.V.), the Finnish Medical Foundation (to A.K.), the Sigrid Juselius Foundation (to I.J. and L.K.), Juho Vainio Foundation (to O.V.), and HUH Funds (TYH2021343 to O.V.).; Belik , M , Jalkanen , P , Lundberg , R , Reinholm , A , Laine , L , Väisänen , E , Skön , M , Tahtinen , P A , Ivaska , L , Pakkanen , S H , Häkkinen , H K , Ortamo , E , Pasternack , A , Ritvos , M A , Naves , R A , Miettinen , S , Sironen , T , Vapalahti , O , Ritvos , O , Österlund , P , Kantele , A , Lempainen , J , Kakkola , L , Kolehmainen , P & Julkunen , I 2022 , ' Comparative analysis of COVID-19 vaccine responses and third booster dose-induced neutralizing antibodies against Delta and Omicron variants ' , Nature Communications , vol. 13 , no. 1 , 2476 . https://doi.org/10.1038/s41467-022-30162-5Test; ORCID: /0000-0002-2344-2755/work/113986535; ORCID: /0000-0003-2270-6824/work/113986545; ORCID: /0000-0003-4522-5337/work/113987458; ORCID: /0000-0002-6088-4245/work/155655390; ORCID: /0009-0002-1107-522X/work/156153294; http://hdl.handle.net/10138/344286Test; b5990a41-ebea-4d23-9e51-fbe2542ffb62; 000791508600018

الإتاحة: http://hdl.handle.net/10138/344286Test

المؤلفون: Jalkanen, Pinja, Kolehmainen, Pekka, Haveri, Anu, Huttunen, Moona, Laine, Larissa, Österlund, Pamela, Tähtinen, Paula A., Ivaska, Lauri, Maljanen, Sari, Reinholm, Arttu, Belik, Milja, Smura, Teemu, Häkkinen, Hanni K., Ortamo, Eeva, Kantele, Anu, Julkunen, Ilkka, Lempainen, Johanna, Kakkola, Laura

المساهمون: Department of Virology, HUSLAB, University of Helsinki, Infektiosairauksien yksikkö, Department of Medicine, HUS Inflammation Center, Clinicum, Helsinki University Hospital Area

مصطلحات موضوعية: COVID-19, coronavirus, vaccines, 3121 General medicine, internal medicine and other clinical medicine

وصف الملف: application/pdf

العلاقة: This work was supported by the Jane and Aatos Erkko Foundation (grant numbers 306784b53 and 5360-cc2fc to I.J.); the Academy of Finland (grant numbers 336410 and 337530 to I.J., and 336439 and 335527 to A.K.); the Sigrid Juselius Foundation (to I.J.); the Finnish Medical Foundation (to A.K.); and The Turku University Hospital Research Foundation (to P.A.T., L.I., and J.L.). This work did not receive funding fromany vaccinemanufacturer.; Jalkanen , P , Kolehmainen , P , Haveri , A , Huttunen , M , Laine , L , Österlund , P , Tähtinen , P A , Ivaska , L , Maljanen , S , Reinholm , A , Belik , M , Smura , T , Häkkinen , H K , Ortamo , E , Kantele , A , Julkunen , I , Lempainen , J & Kakkola , L 2022 , ' Vaccine-Induced Antibody Responses against SARS-CoV-2 Variants-Of-Concern Six Months after the BNT162b2 COVID-19 mRNA Vaccination ' , Microbiology Spectrum , vol. 10 , no. 2 . https://doi.org/10.1128/spectrum.02252-21Test; 54ef2d59-be50-4c5a-a81b-5d64a7af14d4; http://hdl.handle.net/10138/352049Test; 000835142100169

الإتاحة: http://hdl.handle.net/10138/352049Test

المؤلفون: Belik, Milja

المساهمون: Matemaattis-luonnontieteellinen tiedekunta, Faculty of Science, Fysiologia ja genetiikka, Physiology and Genetics, Biologian laitos, Department of Biology

مصطلحات موضوعية: Influenssa A -virus, A/H1N1pdm09, influenssapandemia, sikainfluenssa, replikaatiosykli, adaptaatio

العلاقة: https://www.utupub.fi/handle/10024/152949Test; URN:NBN:fi-fe2021120358900

الإتاحة: https://www.utupub.fi/handle/10024/152949Test